From a biochemical therapeutics standpoint, Relafen 750 (Naproxen ) presents a fascinating case study in medication action. Its mechanism of effect primarily involves the inhibition of cyclooxygenase ( COX mediators) enzymes, particularly the COX-2 isoform, leading to a decrease in the synthesis